logo

Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline

New York, New York--(Newsfile Corp. - July 22, 2025) - If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=157694&wire=5&utm_campaign=15
or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
Cannot view this video? Visit:
https://www.youtube.com/watch?v=bar7Q9XIFkc
THE LAWSUIT: A class action securities lawsuit was filed against Rocket Pharmaceuticals, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025.
CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RP-A501's safety and clinical trial protocol; notably, that Rocket knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Rocket's securities at artificially inflated prices.
On May 27, 2025, Rocket announced that the FDA placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event (SAE), ultimately, death, while enrolled in the study following a substantive amendment to the protocol that the Company failed to disclose to investors at the time management made the revision. In fact, Rocket stated that, while the patient was dosed in May, the decision to amend the protocol was made "several months" earlier. Despite this, Rocket made no attempt to alert investors or the public to the change until after the SAE occurred.
Following this news, the price of Rocket's common stock declined dramatically. From a closing market price of $6.27 per share on May 23, 2025, Rocket's stock price fell to $2.33 per share on May 27, 2025, a decline of about 37% in the span of just a single trading day.
WHAT'S NEXT? If you suffered a loss in Rocket stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=157694&wire=5&utm_campaign=15 to learn about your rights to seek a recovery. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259678
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Coal company wins $142.8-million from Alberta government over policy flip-flop
Coal company wins $142.8-million from Alberta government over policy flip-flop

Globe and Mail

timean hour ago

  • Globe and Mail

Coal company wins $142.8-million from Alberta government over policy flip-flop

A coal company that was suing Alberta as part of a $16-billion lawsuit has reached a $142.8-million settlement over the government's flip-flop on coal policy. Atrum Coal Ltd. has agreed to drop its lawsuit and surrender its coal leases back to the government in exchange for the cash, according to a notice on the company's website. The province paid Atrum $136.8-million earlier this month, but will retain $6-million of the full settlement amount until reclamation works on the site are complete. Atrum said in the notice it would distribute the proceeds of the settlement to its shareholders, minus obligations such as taxes, director compensation, legal fees and amounts needed to cover reclamation works. Details of those amounts and timelines will be released at a later date. The company is one of two that have reached settlements with the province. The other is Evolve Power Ltd. (formerly Montem Resources Ltd.), though it has not yet posted details on its deal with the province. The Alberta government has not yet answered questions from The Globe and Mail about the Atrum settlement. Alberta regulator approves controversial coal exploration applications at Grassy Mountain At the heart of the lawsuits was a series of changes made to provincial coal policy by the United Conservative Party government. In 2020, it nixed land protection rules that dated back to 1976, prompting a furious public backlash that forced the government to reverse its decision the following year. The government then cancelled leases earmarked for potential new mines and declared an indefinite moratorium on coal exploration. In January this year, the Alberta government scrapped the series of ministerial orders that banned coal development in the foothills of the Rocky Mountains, returning to an older policy that in part relies on land categories to govern where mines are built. Companies that had already spent millions developing mine plans moved to recoup some of those costs by suing the province. The result was two lawsuits: one filed in 2023, the other in 2024. The first suit was a joint case involving four separate submissions to Alberta's Court of King's Bench by Evolve, Atrum and its subsidiary Elan Coal Ltd., Cabin Ridge Project Ltd. and Black Eagle Mining Corp. All were pursuing mines for metallurgical coal, which is used for making steel. The other suit was filed in June, 2024, by Northback Holdings Corp. It argued that the joint federal-provincial review of its proposed Grassy Mountain mine in the Crowsnest Pass was flawed and that dozens of provincial officials acted in bad faith when they 'consistently assured Northback that the Grassy Mountain Project would be subject to a fair and transparent regulatory process.'

Publisher McGraw Hill says it has raised $415-million in its U.S. initial public offering
Publisher McGraw Hill says it has raised $415-million in its U.S. initial public offering

Globe and Mail

timean hour ago

  • Globe and Mail

Publisher McGraw Hill says it has raised $415-million in its U.S. initial public offering

U.S. publisher McGraw Hill, backed by investment firm Platinum Equity, said on Wednesday it had raised US$414.63-million in its initial public offering in the United States. The company sold 24,390,000 shares, priced at US$17 each, below its marketed range of US$19 to US$22. The offering valued McGraw at US$3.25-billion. The IPO market is gaining momentum on the back of a rally in equities and some stellar debuts in recent months. Private equity sponsors, who have been sitting on a massive backlog of portfolio companies waiting to go public, are looking to capitalize on this window. McGraw Hill will debut on the New York Stock Exchange on Thursday, nearly 13 years after it was taken private by Apollo . The private-equity giant had also attempted to re-list the company in 2015.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store